Download PDF
Minim Invasive Neurosurg 2009; 52(5/06): 207-211
DOI: 10.1055/s-0029-1241848
Original Article

© Georg Thieme Verlag KG Stuttgart · New York

Microsurgical Treatment for Typical Pituitary Apoplexy with 44 Patients, According to Two Pathological Stages

X.-F. Shou1 , Y.-F. Wang1 , S.-Q. Li1 , J.-S. Wu1 , Y. Zhao1 , Y. Mao1 , L.-F. Zhou1
  • 1Department of Neurosurgery, Shanghai Neurosurgical Center, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, P. R. China
Further Information

Publication History

Publication Date:
14 January 2010 (online)

    Permissions and Reprints

Abstract

Objects: The aim of this study was to explore the pathogenesis of typical pituitary apoplexy in different periods, to help to formulate a reasonable treatment program and to select the correct operation time.

Methods: Forty-four cases with pituitary apoplexy were diagnosed by the clinical presentation, pathological examination and surgical findings. Clinical manifestation, imaging features, surgical and pathological findings, as well as their relationships with the courses of this disease were analyzed retrospectively.

Results: The course of typical pituitary apoplexy was divided into two stages (the early hemorrhagic infarct stage and the late necrosis stage). The total removal rates in the early and late stage were 87.5% (14/16) and 100% (28/28), respectively.

Conclusions: Typical pituitary apoplexy is mainly caused by hemorrhage secondary to necrosis after infarction. The staging of this disease provides an important guidance value to diagnosis and treatment. The surgical outcomes in the late stage were significantly better than those in the early stage. The patients without significant symptoms can be conservatively treated by hormone substitution therapy.

Key words

pituitary adenoma - pituitary apoplexy - microsurgical treatment

References

  • 1 Cardoso ER, Peterson EW. Pituitary apoplexy: a review.  Neurosurgery. 1984;  14 363-373
    CrossrefPubMedSearch in Google Scholar
  • 2 Onesti ST, Wisniewski T, Post KD. Clinical versus subclinical pituitary apoplexy: presentation, surgical management, and outcome in 21 patients.  Neurosurgery. 1990;  26 980-986
    Search in Google Scholar
  • 3 Bills DC, Meyer FB, Laws ER. et al . A retrospective analysis of pituitary apoplexy.  Neurosurgery. 1993;  33 602-608 ; discussion 608–609 
    CrossrefPubMedSearch in Google Scholar
  • 4 Milazzo S, Toussaint P, Proust F. et al . Ophthalmologic aspects of pituitary apoplexy.  Eur J Ophthalmol. 1996;  6 69-73
    CrossrefPubMedSearch in Google Scholar
  • 5 Lubina A, Olchovsky D, Berezin M. et al . Management of pituitary apoplexy: clinical experience with 40 patients.  Acta Neurochir (Wien). 2005;  147 151-157 ; discussion 157 
    CrossrefPubMedSearch in Google Scholar
  • 6 Sibal L, Ball SG, Connolly V. et al . Pituitary apoplexy: a review of clinical presentation, management and outcome in 45 cases.  Pituitary. 2004;  7 157-163
    CrossrefPubMedSearch in Google Scholar
  • 7 Alhajje A, Lambert M, Crabbe J. Pituitary apoplexy in an acromegalic patient during bromocriptine therapy. Case report.  J Neurosurg. 1985;  63 288-292
    CrossrefPubMedSearch in Google Scholar
  • 8 Otsuka F, Kageyama J, Ogura T. et al . Pituitary apoplexy induced by a combined anterior pituitary test: case report and literature review.  Endocr J. 1998;  45 393-398
    CrossrefPubMedSearch in Google Scholar
  • 9 Silberstein L, Johnston C, Bhagat A. et al . Pituitary apoplexy during induction chemotherapy for acute myeloid leukaemia.  Br J Haematol. 2008;  143 151
    CrossrefPubMedSearch in Google Scholar
  • 10 Semple PL, Jane JA, Laws ER. Clinical relevance of precipitating factors in pituitary apoplexy.  Neurosurgery. 2007;  61 956-961 ; discussion 961-962 
    CrossrefPubMedSearch in Google Scholar
  • 11 Muthukumar N, Rossette D, Soundaram M. et al . Blindness following pituitary apoplexy: timing of surgery and neuro-ophthalmic outcome.  J Clin Neurosci. 2008;  15 873-879
    Search in Google Scholar
  • 12 Nielsen EH, Lindholm J, Bjerre P. et al . Frequent occurrence of pituitary apoplexy in patients with non-functioning pituitary adenoma.  Clin Endocrinol (Oxf). 2006;  64 319-322
    CrossrefPubMedSearch in Google Scholar
  • 13 Parikh VP, Talwar I. Computed tomography of hemorrhage in a pituitary adenoma without apoplexy.  J Comput Tomogr. 1988;  12 187-189
    CrossrefPubMedSearch in Google Scholar
  • 14 Semple PL, Jane JA, Lopes MB. et al . Pituitary apoplexy: correlation between magnetic resonance imaging and histopathological results.  J Neurosurg. 2008;  108 909-915
    CrossrefPubMedSearch in Google Scholar
  • 15 Chuang CC, Chang CN, Wei KC. et al . Surgical treatment for severe visual compromised patients after pituitary apoplexy.  J Neurooncol. 2006;  80 39-47
    CrossrefPubMedSearch in Google Scholar
  • 16 Agrawal D, Mahapatra AK. Visual outcome of blind eyes in pituitary apoplexy after transsphenoidal surgery: a series of 14 eyes.  Surg Neurol. 2005;  63 42-46 ; discussion 46 
    CrossrefPubMedSearch in Google Scholar
  • 17 Mou C, Han T, Zhao H. et al . Clinical features and immunohistochemical changes of pituitary apoplexy.  J Clin Neurosci. 2009;  16 64-68
    CrossrefPubMedSearch in Google Scholar
  • 18 Armstrong MR, Douek M, Schellinger D. et al . Regression of pituitary macroadenoma after pituitary apoplexy: CT and MR studies.  J Comput Assist Tomogr. 1991;  15 832-834
    CrossrefPubMedSearch in Google Scholar
  • 19 Landolt AM, Froesch ER, Konig MP. Spontaneous postoperative normalization of growth hormone levels in two patients with acromegaly not cured by transsphenoidal surgery.  Neurosurgery. 1988;  23 634-637
    CrossrefPubMedSearch in Google Scholar

Correspondence

Y.-F. WangMD 

Department of Neurosurgery

Huashan Hospital

No.12 Middle Wulumuqi Road

200040 Shanghai

People's Republic of China

Phone: +86/21/5288 9999

Phone: +86/139/0164 9566

Email: shouxf@hotmail.com